 | • レポートコード：QYR9NV09565 • 出版社/出版日：QYResearch / 2019年11月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、パーキンソン病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、シネメット-CR、トラスター、マドパル、COMT阻害剤、その他に、用途別には、40歳未満、40-65歳、65歳以上にセグメント区分し、パーキンソン病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・パーキンソン病薬の世界市場概要 ・パーキンソン病薬の製造コスト構成分析 ・パーキンソン病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・パーキンソン病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・パーキンソン病薬のセグメント分析（種類別） （シネメット-CR、トラスター、マドパル、COMT阻害剤、その他） ・パーキンソン病薬のセグメント分析（用途別） （40歳未満、40-65歳、65歳以上） ・パーキンソン病薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Merck、Akorn、GSK、Novartis、Boehringer Ingelheim、Teva Pharmaceutical、Abbvie、Kyowa Hakko Kirin Pharma、Astellas Pharma、Desitin Arzneimittel、Endo Pharmaceuticals、F.Hoffmann-La Roche、H.Lundbeck、Valeant、Apokyn、Orion、Stada Arzneimittel、US WorldMeds、Valeant Pharmaceuticals、） ・パーキンソン病薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Parkinson’s Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Parkinson’s Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson’s Disease Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Parkinson’s Disease Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Parkinson’s Disease Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Valeant Pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Segment by Application
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Table of Contents
Executive Summary
1 Industry Overview of Parkinson’s Disease Drug
1.1 Definition of Parkinson’s Disease Drug
1.2 Parkinson’s Disease Drug Segment by Type
1.2.1 Global Parkinson’s Disease Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Parkinson’s Disease Drug Segment by Applications
1.3.1 Global Parkinson’s Disease Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Global Parkinson’s Disease Drug Overall Market
1.4.1 Global Parkinson’s Disease Drug Revenue (2014-2025)
1.4.2 Global Parkinson’s Disease Drug Production (2014-2025)
1.4.3 North America Parkinson’s Disease Drug Status and Prospect (2014-2025)
1.4.4 Europe Parkinson’s Disease Drug Status and Prospect (2014-2025)
1.4.5 China Parkinson’s Disease Drug Status and Prospect (2014-2025)
1.4.6 Japan Parkinson’s Disease Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Parkinson’s Disease Drug Status and Prospect (2014-2025)
1.4.8 India Parkinson’s Disease Drug Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Parkinson’s Disease Drug
2.3 Manufacturing Process Analysis of Parkinson’s Disease Drug
2.4 Industry Chain Structure of Parkinson’s Disease Drug
3 Development and Manufacturing Plants Analysis of Parkinson’s Disease Drug
3.1 Capacity and Commercial Production Date
3.2 Global Parkinson’s Disease Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Parkinson’s Disease Drug
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Parkinson’s Disease Drug Production and Capacity Analysis
4.2 Parkinson’s Disease Drug Revenue Analysis
4.3 Parkinson’s Disease Drug Price Analysis
4.4 Market Concentration Degree
5 Parkinson’s Disease Drug Regional Market Analysis
5.1 Parkinson’s Disease Drug Production by Regions
5.1.1 Global Parkinson’s Disease Drug Production by Regions
5.1.2 Global Parkinson’s Disease Drug Revenue by Regions
5.2 Parkinson’s Disease Drug Consumption by Regions
5.3 North America Parkinson’s Disease Drug Market Analysis
5.3.1 North America Parkinson’s Disease Drug Production
5.3.2 North America Parkinson’s Disease Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Parkinson’s Disease Drug Import and Export
5.4 Europe Parkinson’s Disease Drug Market Analysis
5.4.1 Europe Parkinson’s Disease Drug Production
5.4.2 Europe Parkinson’s Disease Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Parkinson’s Disease Drug Import and Export
5.5 China Parkinson’s Disease Drug Market Analysis
5.5.1 China Parkinson’s Disease Drug Production
5.5.2 China Parkinson’s Disease Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Parkinson’s Disease Drug Import and Export
5.6 Japan Parkinson’s Disease Drug Market Analysis
5.6.1 Japan Parkinson’s Disease Drug Production
5.6.2 Japan Parkinson’s Disease Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Parkinson’s Disease Drug Import and Export
5.7 Southeast Asia Parkinson’s Disease Drug Market Analysis
5.7.1 Southeast Asia Parkinson’s Disease Drug Production
5.7.2 Southeast Asia Parkinson’s Disease Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Parkinson’s Disease Drug Import and Export
5.8 India Parkinson’s Disease Drug Market Analysis
5.8.1 India Parkinson’s Disease Drug Production
5.8.2 India Parkinson’s Disease Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Parkinson’s Disease Drug Import and Export
6 Parkinson’s Disease Drug Segment Market Analysis (by Type)
6.1 Global Parkinson’s Disease Drug Production by Type
6.2 Global Parkinson’s Disease Drug Revenue by Type
6.3 Parkinson’s Disease Drug Price by Type
7 Parkinson’s Disease Drug Segment Market Analysis (by Application)
7.1 Global Parkinson’s Disease Drug Consumption by Application
7.2 Global Parkinson’s Disease Drug Consumption Market Share by Application (2014-2019)
8 Parkinson’s Disease Drug Major Manufacturers Analysis
8.1 Merck
8.1.1 Merck Parkinson’s Disease Drug Production Sites and Area Served
8.1.2 Merck Product Introduction, Application and Specification
8.1.3 Merck Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Akorn
8.2.1 Akorn Parkinson’s Disease Drug Production Sites and Area Served
8.2.2 Akorn Product Introduction, Application and Specification
8.2.3 Akorn Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 GSK
8.3.1 GSK Parkinson’s Disease Drug Production Sites and Area Served
8.3.2 GSK Product Introduction, Application and Specification
8.3.3 GSK Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Novartis
8.4.1 Novartis Parkinson’s Disease Drug Production Sites and Area Served
8.4.2 Novartis Product Introduction, Application and Specification
8.4.3 Novartis Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Boehringer Ingelheim
8.5.1 Boehringer Ingelheim Parkinson’s Disease Drug Production Sites and Area Served
8.5.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.5.3 Boehringer Ingelheim Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Teva Pharmaceutical
8.6.1 Teva Pharmaceutical Parkinson’s Disease Drug Production Sites and Area Served
8.6.2 Teva Pharmaceutical Product Introduction, Application and Specification
8.6.3 Teva Pharmaceutical Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Abbvie
8.7.1 Abbvie Parkinson’s Disease Drug Production Sites and Area Served
8.7.2 Abbvie Product Introduction, Application and Specification
8.7.3 Abbvie Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Kyowa Hakko Kirin Pharma
8.8.1 Kyowa Hakko Kirin Pharma Parkinson’s Disease Drug Production Sites and Area Served
8.8.2 Kyowa Hakko Kirin Pharma Product Introduction, Application and Specification
8.8.3 Kyowa Hakko Kirin Pharma Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Astellas Pharma
8.9.1 Astellas Pharma Parkinson’s Disease Drug Production Sites and Area Served
8.9.2 Astellas Pharma Product Introduction, Application and Specification
8.9.3 Astellas Pharma Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Desitin Arzneimittel
8.10.1 Desitin Arzneimittel Parkinson’s Disease Drug Production Sites and Area Served
8.10.2 Desitin Arzneimittel Product Introduction, Application and Specification
8.10.3 Desitin Arzneimittel Parkinson’s Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Endo Pharmaceuticals
8.12 F.Hoffmann-La Roche
8.13 H.Lundbeck
8.14 Valeant
8.15 Apokyn
8.16 Orion
8.17 Stada Arzneimittel
8.18 US WorldMeds
8.19 Valeant Pharmaceuticals
9 Development Trend of Analysis of Parkinson’s Disease Drug Market
9.1 Global Parkinson’s Disease Drug Market Trend Analysis
9.1.1 Global Parkinson’s Disease Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Parkinson’s Disease Drug Regional Market Trend
9.2.1 North America Parkinson’s Disease Drug Forecast 2019-2025
9.2.2 Europe Parkinson’s Disease Drug Forecast 2019-2025
9.2.3 China Parkinson’s Disease Drug Forecast 2019-2025
9.2.4 Japan Parkinson’s Disease Drug Forecast 2019-2025
9.2.5 Southeast Asia Parkinson’s Disease Drug Forecast 2019-2025
9.2.6 India Parkinson’s Disease Drug Forecast 2019-2025
9.3 Parkinson’s Disease Drug Market Trend (Product Type)
9.4 Parkinson’s Disease Drug Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Parkinson’s Disease Drug Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Parkinson's Disease Drug
Table Global Parkinson's Disease Drug Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Parkinson's Disease Drug Production Market Share by Types in 2018
Figure Sinemet-CR Product Picture
Figure Trastal Product Picture
Figure Madopar Product Picture
Figure COMT Inhibitor Product Picture
Figure Other Product Picture
Table Global Parkinson's Disease Drug Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Parkinson's Disease Drug Consumption Market Share by Applications in 2018
Figure Under 40 Years Old
Figure 40-65 Years Old
Figure Above 65 Years Old
Figure Global Parkinson's Disease Drug Revenue (Million USD) (2014-2025)
Figure Global Parkinson's Disease Drug Production (K Units) (2014-2025)
Figure North America Parkinson's Disease Drug Market Size (Million USD) (2014-2025)
Figure Europe Parkinson's Disease Drug Market Size (Million USD) (2014-2025)
Figure China Parkinson's Disease Drug Market Size (Million USD) (2014-2025)
Figure Japan Parkinson's Disease Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Parkinson's Disease Drug Market Size (Million USD) (2014-2025)
Figure India Parkinson's Disease Drug Market Size (Million USD) (2014-2025)
Table Parkinson's Disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Parkinson's Disease Drug in 2018
Figure Manufacturing Process Analysis of Parkinson's Disease Drug
Figure Industry Chain Structure of Parkinson's Disease Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Parkinson's Disease Drug Manufacturing Plants Distribution
Table Parkinson's Disease Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Parkinson's Disease Drug Capacity (K Units) of Major Manufacturers (2014-2019)
Table Parkinson's Disease Drug Production (K Units) of Major Manufacturers (2014-2019)
Table Parkinson's Disease Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Parkinson's Disease Drug Production Share by Manufacturers in 2018
Table Parkinson's Disease Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Parkinson's Disease Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Parkinson's Disease Drug Revenue Share by Manufacturers in 2018
Table Parkinson's Disease Drug Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Parkinson's Disease Drug Production by Regions 2014-2019 (K Units)
Table Global Parkinson's Disease Drug Production Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Drug Production Market Share by Regions in 2018
Table Global Parkinson's Disease Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Parkinson's Disease Drug Revenue Market Share by Regions 2014-2019
Figure Global Parkinson's Disease Drug Revenue Market Share by Regions in 2018
Table Global Parkinson's Disease Drug Consumption by Regions 2014-2019 (K Units)
Table Global Parkinson's Disease Drug Consumption Market Share by Regions 2014-2019
Figure North America Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units)
Figure North America Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Parkinson's Disease Drug Production, Consumption Import and Export (K Units)
Figure Europe Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units)
Figure Europe Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Parkinson's Disease Drug Production, Consumption Import and Export (K Units)
Figure China Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units)
Figure China Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Parkinson's Disease Drug Production, Consumption Import and Export (K Units)
Figure Japan Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units)
Figure Japan Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Parkinson's Disease Drug Production, Consumption Import and Export (K Units)
Figure Southeast Asia Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Parkinson's Disease Drug Production, Consumption Import and Export (K Units)
Figure India Parkinson's Disease Drug Production Growth Rate 2014-2019 (K Units)
Figure India Parkinson's Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Parkinson's Disease Drug Production, Consumption Import and Export (K Units)
Figure Global Consumption Parkinson's Disease Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Parkinson's Disease Drug Market Share by Application (2014-2019)
Table Merck Parkinson's Disease Drug Production Sites and Area Served
Table Merck Parkinson's Disease Drug Product Introduction, Application and Specification
Table Merck Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Merck Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Merck Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Merck Parkinson's Disease Drug Main Business and Markets Served
Table Akorn Parkinson's Disease Drug Production Sites and Area Served
Table Akorn Parkinson's Disease Drug Product Introduction, Application and Specification
Table Akorn Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Akorn Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Akorn Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Akorn Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Akorn Parkinson's Disease Drug Main Business and Markets Served
Table GSK Parkinson's Disease Drug Production Sites and Area Served
Table GSK Parkinson's Disease Drug Product Introduction, Application and Specification
Table GSK Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table GSK Parkinson's Disease Drug Production Market Share (2014-2019)
Figure GSK Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table GSK Parkinson's Disease Drug Main Business and Markets Served
Table Novartis Parkinson's Disease Drug Production Sites and Area Served
Table Novartis Parkinson's Disease Drug Product Introduction, Application and Specification
Table Novartis Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Novartis Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Novartis Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Novartis Parkinson's Disease Drug Main Business and Markets Served
Table Boehringer Ingelheim Parkinson's Disease Drug Production Sites and Area Served
Table Boehringer Ingelheim Parkinson's Disease Drug Product Introduction, Application and Specification
Table Boehringer Ingelheim Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Boehringer Ingelheim Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Parkinson's Disease Drug Main Business and Markets Served
Table Teva Pharmaceutical Parkinson's Disease Drug Production Sites and Area Served
Table Teva Pharmaceutical Parkinson's Disease Drug Product Introduction, Application and Specification
Table Teva Pharmaceutical Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Teva Pharmaceutical Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Parkinson's Disease Drug Main Business and Markets Served
Table Abbvie Parkinson's Disease Drug Production Sites and Area Served
Table Abbvie Parkinson's Disease Drug Product Introduction, Application and Specification
Table Abbvie Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbvie Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Abbvie Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Abbvie Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Abbvie Parkinson's Disease Drug Main Business and Markets Served
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Sites and Area Served
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Product Introduction, Application and Specification
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Main Business and Markets Served
Table Astellas Pharma Parkinson's Disease Drug Production Sites and Area Served
Table Astellas Pharma Parkinson's Disease Drug Product Introduction, Application and Specification
Table Astellas Pharma Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharma Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Astellas Pharma Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Astellas Pharma Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Astellas Pharma Parkinson's Disease Drug Main Business and Markets Served
Table Desitin Arzneimittel Parkinson's Disease Drug Production Sites and Area Served
Table Desitin Arzneimittel Parkinson's Disease Drug Product Introduction, Application and Specification
Table Desitin Arzneimittel Parkinson's Disease Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Desitin Arzneimittel Parkinson's Disease Drug Production Growth Rate (2014-2019)
Table Desitin Arzneimittel Parkinson's Disease Drug Production Market Share (2014-2019)
Figure Desitin Arzneimittel Parkinson's Disease Drug Revenue Market Share (2014-2019)
Table Desitin Arzneimittel Parkinson's Disease Drug Main Business and Markets Served
Table Endo Pharmaceuticals Parkinson's Disease Drug Production Sites and Area Served
Table F.Hoffmann-La Roche Parkinson's Disease Drug Production Sites and Area Served
Table H.Lundbeck Parkinson's Disease Drug Production Sites and Area Served
Table Valeant Parkinson's Disease Drug Production Sites and Area Served
Table Apokyn Parkinson's Disease Drug Production Sites and Area Served
Table Orion Parkinson's Disease Drug Production Sites and Area Served
Table Stada Arzneimittel Parkinson's Disease Drug Production Sites and Area Served
Table US WorldMeds Parkinson's Disease Drug Production Sites and Area Served
Table Valeant Pharmaceuticals Parkinson's Disease Drug Production Sites and Area Served
Figure Global Parkinson's Disease Drug Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Parkinson's Disease Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Parkinson's Disease Drug Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Parkinson's Disease Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Parkinson's Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Parkinson's Disease Drug by Type (2019-2025)
Table Global Consumption (K Units) of Parkinson's Disease Drug by Application (2019-2025)
Table Parkinson's Disease Drug Distributors List
Table Parkinson's Disease Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
クローン病薬のグローバル市場調査 2019年 The global Crohn’s Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Crohn’s Disease Drug volume and value at global level, regional level and company level. From a global perspective, th…- 胃食道逆流症（GERD）薬のグローバル市場調査 2019年 The global Gastro Esophageal Reflux Disease (GERD) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Gastro Esophageal Reflux Disease (GERD) Drug volume and value at global level, regional level …
- デビック病薬のグローバル市場調査 2019年 The global Devic's Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Devic's Disease Drug volume and value at global level, regional level and company level. From a global perspective, th…
- 世界及び中国の胃食道逆流疾患 (GERD) 治療薬市場2018 The 'Global and Chinese Gastro Esophageal Reflux Disease (GERD) Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Gastro Esophageal Reflux Disease (GERD) Drug industry with a focus on the Chinese market. The report provides key s…
- シャーガス病薬のグローバル市場調査 2019年 The global Chagas Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Chagas Disease Drug volume and value at global level, regional level and company level. From a global perspective, this…